(Q46601277)

23 December 2017

title

Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine (English)

1 reference

23 December 2017

1 reference

1 reference

1 reference

1 reference

Jairam Sastry

1

1 reference

23 December 2017

Stewart J Kellie

series ordinal

2

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

Pediatric Hematology and Oncology

published in

1 reference

23 December 2017

volume

22

1 reference

23 December 2017

issue

5

1 reference

23 December 2017

page(s)

441-445

1 reference

23 December 2017

Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08880010590964381

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010590964381

Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010590964381

Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010590964381

Amifostine in clinical oncology: current use and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010590964381

Amifostine: potential for clinically useful cytoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010590964381

Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010590964381

10.1080/08880010590964381

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

16020136

1 reference

23 December 2017